Schizophrenia Research Trends

160A. Orosz, K. Cattapan-Ludewig, G. Gal and J. Feldon[76] Thornton JC, Dawe S, Lee C, Capstick C, Corr PJ, Cotter P et al. Effects of nicotineand amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl)1996; 127(2):164-173.[77] Salgado JV, Hetem LA, Vidal M, Graeff FG, Danion JM, Sandner G. Reduction oflatent inhibition by D-amphetamine in a conditioned suppression paradigm in humans.Behav Brain Res 2000; 117(1-2):61-67.[78] Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA. Abolition of latentinhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology (Berl)1992; 107(2-3):425-430.[79] Kumari V, Cotter PA, Mulligan OF, Checkley SA, Gray NS, Hemsley DR et al. Effectsof d-amphetamine and haloperidol on latent inhibition in healthy male volunteers. JPsychopharmacol 1999; 13(4):398-405.[80] Janowsky DS, el Yousel MK, Davis JM, Sekerke HJ. Provocation of schizophrenicsymptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry1973; 28(2):185-191.[81] Rascle C, Mazas O, Vaiva G, Tournant M, Raybois O, Goudemand M et al. Clinicalfeatures of latent inhibition in schizophrenia. Schizophr Res 2001; 51(2-3):149-161.[82] Gray NS, Hemsley DR, Gray JA. Abolition of latent inhibition in acute, but not chronicschizophrenia. Neurol Psychiatr Brain Res 1992; 1:83-89.[83] Martins SA, Jones SH, Toone B, Gray JA. Impaired associative learning in chronicschizophrenics and their first-degree relatives: a study of latent inhibition and theKamin blocking effect. Schizophr Res 2001; 48(2-3):273-289.[84] Cohen E, Sereni N, Kaplan O, Weizman A, Kikinzon L, Weiner I et al. The relationbetween latent inhibition and symptom-types in young schizophrenics. Behav BrainRes 2004; 149(2):113-122.[85] Williams JH, Wellman NA, Geaney DP, Cowen PJ, Feldon J, Rawlins JN.Antipsychotic drug effects in a model of schizophrenic attentional disorder: arandomized controlled trial of the effects of haloperidol on latent inhibition in healthypeople. Biol Psychiatry 1996; 40(11):1135-1143.[86] Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopaminetransmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999;46(1):56-72.[87] Kremer EF. Truly random and traditional control procedures in CER conditioning inthe rat. J Comp Physiol Psychol 1971; 76(3):441-448.[88] Randich A, LoLordo VM. Associative and nonassociative theories of the UCSpreexposure phenomenon: implications for Pavlovian conditioning. Psychol Bull 1979;86(3):523-548.[89] Meyer U, Chang dL, Feldon J, Yee BK. Expression of the CS- and US-pre-exposureeffects in the conditioned taste aversion paradigm and their abolition followingsystemic amphetamine treatment in C57BL6/J mice. Neuropsychopharmacology 2004;29(12):2140-2148.[90] Bennett CH, Maldonado A, Mackintosh NJ. Learned irrelevance is not the sum ofexposure to CS and US. Q J Exp Psychol B 1995; 48(2):117-128.